Photo

Photo detail

Obalon Therapeutics won FDA for its weight-loss pill, a dissolvable capsule that contains a folded gastric balloon. Photo by Obalon Therapeutics

Stories this photo appears in:

Obalon Therapeutics Announces $75M IPO; Gets FDA Approval

San Diego’s Obalon Therapeutics is on a roll. After announcing a $75 million IPO on Friday, the company said this morning that it has received FDA approval of its lead product: the Obalon Balloon System.

Tease photo